These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12966108)

  • 1. Emerging infections and bioterrorism raise profile of schools of public health.
    Lovinger SP
    JAMA; 2003 Sep; 290(10):1306-7. PubMed ID: 12966108
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective public health assessment, prevention, response, and training for emerging and re-emerging infectious diseases, including bioterrorism.
    American Public Health Association
    Am J Public Health; 2001 Mar; 91(3):500-1. PubMed ID: 11236439
    [No Abstract]   [Full Text] [Related]  

  • 3. A plague on your city: observations from TOPOFF.
    Inglesby TV; Grossman R; O'Toole T
    Clin Infect Dis; 2001 Feb; 32(3):436-45. PubMed ID: 11170952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the legal and ethical preparedness of master of public health graduates.
    Agee B; Gimbel RW
    Am J Public Health; 2009 Aug; 99(8):1505-9. PubMed ID: 18633077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving response to terror and global emerging infectious disease.
    Winkenwerder W
    Manag Care; 2003 Nov; 12(11 Suppl):2-6. PubMed ID: 14669385
    [No Abstract]   [Full Text] [Related]  

  • 6. Caught between paradise and power: public health, pathogenic threats, and the axis of illness.
    Fidler DP
    McGeorge Law Rev; 2004; 35(1):45-104. PubMed ID: 17063603
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioterrorism defense education: prioritizing public health education.
    Egan EA
    Am J Bioeth; 2005; 5(4):47-8. PubMed ID: 16109696
    [No Abstract]   [Full Text] [Related]  

  • 8. A passion for public health.
    Kahler SC
    J Am Vet Med Assoc; 2007 Apr; 230(7):975, 983-4. PubMed ID: 17407858
    [No Abstract]   [Full Text] [Related]  

  • 9. Interview with Julie L. Gerberding, M.D., M.P.H. Director, Centers for Disease Control and Prevention. Interview by Madeline Drexler.
    Gerberding JL
    Biosecur Bioterror; 2003; 1(1):15-8. PubMed ID: 15040210
    [No Abstract]   [Full Text] [Related]  

  • 10. Julie Louise Gerberding--director of the Centers for Disease Control and Prevention. Interview by Pam Das.
    Gerberding JL
    Lancet Infect Dis; 2004 Mar; 4(3):178-81. PubMed ID: 14998505
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging infectious diseases: a CDC perspective.
    Hughes JM
    Emerg Infect Dis; 2001; 7(3 Suppl):494-6. PubMed ID: 11485640
    [No Abstract]   [Full Text] [Related]  

  • 12. Protecting public health in the age of emerging infections.
    Lev O; Rager-Zisman B
    Isr Med Assoc J; 2014 Nov; 16(11):677-82. PubMed ID: 25558694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Center for the Study of Bioterrorism and Emerging Infections: training the public health workforce for the future.
    Evans RG; Shadel BN; Clements B
    Public Health Rep; 2001; 116(3):276-7. PubMed ID: 12034919
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections.
    Pien BC; Saah JR; Miller SE; Woods CW
    Clin Infect Dis; 2006 May; 42(9):1311-24. PubMed ID: 16586392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs.
    Madjid M; Luepker RV; Greenland KJ; Taubert KA; Roy MJ; Robertson RM
    Circulation; 2007 Mar; 115(12):1690-5. PubMed ID: 17506124
    [No Abstract]   [Full Text] [Related]  

  • 16. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs.
    Madjid M; Luepker RV; Greenlund KJ; Taubert KA; Roy MJ; Robertson RM
    J Am Coll Cardiol; 2007 Mar; 49(12):1407-12. PubMed ID: 17394982
    [No Abstract]   [Full Text] [Related]  

  • 17. Burdens of biodefence.
    Kaplan K
    Nature; 2010 May; 465(7296):386-7. PubMed ID: 20564800
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on emerging infections:news from the Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003.
    Barrett TW; Moran GJ
    Ann Emerg Med; 2004 Jan; 43(1):43-5; discussion 45-7. PubMed ID: 14707939
    [No Abstract]   [Full Text] [Related]  

  • 19. Interview with Mark Klempner, MD, principal investigator, National Emerging Infectious Diseases Laboratories, and associate provost for research, Boston University School of Medicine.
    Klempner M
    Biosecur Bioterror; 2006; 4(2):107-12. PubMed ID: 16792478
    [No Abstract]   [Full Text] [Related]  

  • 20. Networking for public health education and training--the need of the hour.
    Nandan D; Dobe M
    Indian J Public Health; 2007; 51(3):139-41. PubMed ID: 18229436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.